1
|
de Carvalho Bertozo L, Tadeu HC, Sebastian A, Maszota-Zieleniak M, Samsonov SA, Ximenes VF. Role for Carboxylic Acid Moiety in NSAIDs: Favoring the Binding at Site II of Bovine Serum Albumin. Mol Pharm 2024; 21:2501-2511. [PMID: 38574292 DOI: 10.1021/acs.molpharmaceut.4c00044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/06/2024]
Abstract
The molecular structures of nonsteroidal anti-inflammatory drugs (NSAIDs) vary, but most contain a carboxylic acid functional group (RCOOH). This functional group is known to be related to the mechanism of cyclooxygenase inhibition and also causes side effects, such as gastrointestinal bleeding. This study proposes a new role for RCOOH in NSAIDs: facilitating the interaction at the binding site II of serum albumins. We used bovine serum albumin (BSA) as a model to investigate the interactions with ligands at site II. Using dansyl-proline (DP) as a fluorescent site II marker, we demonstrated that only negatively charged NSAIDs such as ibuprofen (IBP), naproxen (NPX), diflunisal (DFS), and ketoprofen (KTP) can efficiently displace DP from the albumin binding site. We confirmed the importance of RCOO by neutralizing IBP and NPX through esterification, which reduced the displacement of DP. The competition was also monitored by stopped-flow experiments. While IBP and NPX displaced DP in less than 1 s, the ester derivatives were ineffective. We also observed a higher affinity of negatively charged NSAIDs using DFS as a probe and ultrafiltration experiments. Molecular docking simulations showed an essential salt bridge between the positively charged residues Arg409 and Lys413 with RCOO-, consistent with the experimental findings. We performed a ligand dissociation pathway and corresponding energy analysis by applying molecular dynamics. The dissociation of NPX showed a higher free energy barrier than its ester. Apart from BSA, we conducted some experimental studies with human serum albumin, and similar results were obtained, suggesting a general effect for other mammalian serum albumins. Our findings support that the RCOOH moiety affects not only the mechanism of action and side effects but also the pharmacokinetics of NSAIDs.
Collapse
Affiliation(s)
- Luiza de Carvalho Bertozo
- Department of Chemistry, Faculty of Sciences, UNESP─São Paulo State University, Bauru 17033-360, São Paulo, Brazil
| | - Hugo Cesar Tadeu
- Department of Chemistry, Faculty of Sciences, UNESP─São Paulo State University, Bauru 17033-360, São Paulo, Brazil
| | - Anila Sebastian
- Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland
| | | | - Sergey A Samsonov
- Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland
| | - Valdecir Farias Ximenes
- Department of Chemistry, Faculty of Sciences, UNESP─São Paulo State University, Bauru 17033-360, São Paulo, Brazil
| |
Collapse
|
2
|
Singh H, Yadav I, Sheikh WM, Dan A, Darban Z, Shah SA, Mishra NC, Shahabuddin S, Hassan S, Bashir SM, Dhanka M. Dual cross-linked gellan gum/gelatin-based multifunctional nanocomposite hydrogel scaffold for full-thickness wound healing. Int J Biol Macromol 2023; 251:126349. [PMID: 37591426 DOI: 10.1016/j.ijbiomac.2023.126349] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 07/31/2023] [Accepted: 08/13/2023] [Indexed: 08/19/2023]
Abstract
Biological macromolecules are excellent materials for wound dressing owing to their similar structure to the extracellular matrix and adjustable physicochemical properties. This research focuses on fabricating biological macromolecule-based hydrogel with desirable antibacterial, antioxidant, controlled drug release, cytocompatibility, and wound healing properties. Herein, different concentrations of nanoceria (NC) and flurbiprofen (FLU) drug-loaded gellan gum/gelatin (GG/Ge) based dual crosslinked (Ionic and EDC/NHS coupling) hydrogels were engineered. All fabricated hydrogels were hydrophilic, biodegradable, good strength, porous, antioxidant, hemocompatible and cytocompatible. Among all, hydrogel loaded with 500 μg/ml NC (GG/Ge/NC@FLU) exhibited desirable antioxidant, antibacterial (killed Staphylococcus aureus and Escherichia coli within 12 h), hemocompatible, cytocompatible, supports oxidative-stressed L929 cell growth and acted as a controlled release matrix for FLU, following Fickian diffusion, Peppas Sahlin and Korsmeyer-Peppas drug release models. Furthermore, nanocomposite hydrogel (GG/Ge/NC@FLU)-treated wounds of rats on day 14 demonstrated significantly higher collagen synthesis, nearly 100 % wound contractions, and efficiently decreased the expression of TNF-α and IL-1 while increasing the production of IL-10 and TNF-ß3, indicating antiinflammatory activity, and effectively reduced the expression of VEGF gene indicating effective angiogenesis than all other controls. In conclusion, the fabricated multifunctional GG/Ge/NC@FLU nanocomposite hydrogel shows promising potential for effectively treating full-thickness wound healing in a rat model.
Collapse
Affiliation(s)
- Hemant Singh
- Biological Engineering, Indian Institute of Technology Gandhinagar, Gujarat, India
| | - Indu Yadav
- Polymer and Process Engineering, Indian Institute of Technology Roorkee, Uttarakhand, India
| | - Wajid Mohammad Sheikh
- Biochemistry & Molecular Biology Lab, Division of Veterinary Biochemistry, Faculty of Veterinary Sciences and Animal Husbandry, Sher-e-Kashmir University of Agricultural Sciences and Technology, Srinagar, Jammu and Kashmir, India
| | - Aniruddha Dan
- Biological Engineering, Indian Institute of Technology Gandhinagar, Gujarat, India
| | - Zenab Darban
- Department of Chemistry, Pandit Deendayal Energy University, Gandhinagar, Gujarat, India
| | - Showkat Ahmad Shah
- Division of Veterinary Pathology, Faculty of Veterinary Sciences and Animal Husbandry, Sher-e-Kashmir University of Agricultural Sciences and Technology, Srinagar, Jammu and Kashmir, India
| | - Narayan Chandra Mishra
- Polymer and Process Engineering, Indian Institute of Technology Roorkee, Uttarakhand, India.
| | - Syed Shahabuddin
- Department of Chemistry, Pandit Deendayal Energy University, Gandhinagar, Gujarat, India
| | - Shabir Hassan
- Department of Biology, Khalifa University, Abu Dhabi, United Arab Emirates
| | - Showkeen Muzamil Bashir
- Biochemistry & Molecular Biology Lab, Division of Veterinary Biochemistry, Faculty of Veterinary Sciences and Animal Husbandry, Sher-e-Kashmir University of Agricultural Sciences and Technology, Srinagar, Jammu and Kashmir, India.
| | - Mukesh Dhanka
- Biological Engineering, Indian Institute of Technology Gandhinagar, Gujarat, India.
| |
Collapse
|
3
|
Vemula D, Jayasurya P, Sushmitha V, Kumar YN, Bhandari V. CADD, AI and ML in drug discovery: A comprehensive review. Eur J Pharm Sci 2023; 181:106324. [PMID: 36347444 DOI: 10.1016/j.ejps.2022.106324] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2022] [Revised: 10/26/2022] [Accepted: 11/03/2022] [Indexed: 11/06/2022]
Abstract
Computer-aided drug design (CADD) is an emerging field that has drawn a lot of interest because of its potential to expedite and lower the cost of the drug development process. Drug discovery research is expensive and time-consuming, and it frequently took 10-15 years for a drug to be commercially available. CADD has significantly impacted this area of research. Further, the combination of CADD with Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning (DL) technologies to handle enormous amounts of biological data has reduced the time and cost associated with the drug development process. This review will discuss how CADD, AI, ML, and DL approaches help identify drug candidates and various other steps of the drug discovery process. It will also provide a detailed overview of the different in silico tools used and how these approaches interact.
Collapse
Affiliation(s)
- Divya Vemula
- National Institute of Pharmaceutical Education and Research- Hyderabad, India
| | - Perka Jayasurya
- National Institute of Pharmaceutical Education and Research- Hyderabad, India
| | - Varthiya Sushmitha
- National Institute of Pharmaceutical Education and Research- Hyderabad, India
| | | | - Vasundhra Bhandari
- National Institute of Pharmaceutical Education and Research- Hyderabad, India.
| |
Collapse
|
4
|
Taşkor Önel G, Saygılı N. Synthesis and Cyclooxygenase Enzyme Inhibitory Activity of Flurbiprofen Analogues: Simple Methodology of Their Nanoemulsion Systems. ChemistrySelect 2022. [DOI: 10.1002/slct.202201654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Gülce Taşkor Önel
- Department of Analytical Chemistry Faculty of Pharmacy Erzincan Binali Yıldırım University Yalnızbağ 24100 Erzincan Turkey
| | - Nezire Saygılı
- Department of Basic Pharmaceutical Sciences Faculty of Pharmacy Hacettepe University Sıhhiye 06100 Ankara Turkey
| |
Collapse
|
5
|
Munir MU, Ikraam M, Nadeem M, Khalid SH, Asghar S, Khalid I, Irfan M, Islam N, Ajaz N, Khan IU. Fabrication, In Vitro and In Vivo Evaluation of Non-Ordered Mesoporous Silica-Based Ternary Solid Dispersions for Enhanced Solubility of Flurbiprofen. Pharmaceuticals (Basel) 2022; 15:ph15070856. [PMID: 35890153 PMCID: PMC9324605 DOI: 10.3390/ph15070856] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 06/20/2022] [Accepted: 07/08/2022] [Indexed: 11/23/2022] Open
Abstract
The aim of this study was to improve the solubility and prevent the ulcerogenic effect of flurbiprofen. Initially, binary and ternary solid dispersions (BSDs and TSDs) of flurbiprofen were prepared by using non-ordered mesoporous silica and gelucire. After preformulation testing (solubility, flow properties, % yield, and entrapment efficiency), four formulations were selected for further detailed studies. Solid-state characterization of optimized formulations (S1, S6, S7, and S12) showed successful drug incorporation in the solid dispersion at the molecular state without any noticeable interactions. The in vitro solubility and release study showed an increase in solubility and 98–100% of drug release in 30–45 min. The in vivo gastro-protective effect of the optimized formulations containing flurbiprofen and silica (1:1) with 25% w/w gelucire (S6 and S12) showed a reduction in the gastric lesion index (GLI) after four days of treatment. Moreover, histological images of the stomach lining (S6 and S12) illustrated normal epithelial cells and a partially protected mucosal membrane. Thus, TSD exhibited a significant increase in solubility and the dissolution rate and reduced the gastric ulceration. Therefore, TSDs are dubbed as efficacious carriers to enhance the bioavailability of flurbiprofen while simultaneously reducing its side effects.
Collapse
Affiliation(s)
- Muhammad Usman Munir
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University Sakaka, Aljouf 72388, Saudi Arabia;
| | - Mahnoor Ikraam
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Muhammad Nadeem
- Department of Medicine, Xi’an Jiaotong University, Xi’an 710000, China;
| | - Syed Haroon Khalid
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Sajid Asghar
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
- Correspondence: (S.A.); (I.U.K.)
| | - Ikrima Khalid
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Muhammad Irfan
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Nayyer Islam
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Nyla Ajaz
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
| | - Ikram Ullah Khan
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan; (M.I.); (S.H.K.); (I.K.); (M.I.); (N.I.); (N.A.)
- Correspondence: (S.A.); (I.U.K.)
| |
Collapse
|
6
|
Sodano F, Cristiano C, Rolando B, Marini E, Lazzarato L, Cuozzo M, Albrizio S, Russo R, Rimoli MG. Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs. Pharmaceuticals (Basel) 2022; 15:ph15050552. [PMID: 35631377 PMCID: PMC9142922 DOI: 10.3390/ph15050552] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Revised: 04/25/2022] [Accepted: 04/27/2022] [Indexed: 02/04/2023] Open
Abstract
Carbohydrates are one of the most abundant and important classes of biomolecules. The variety in their structures makes them valuable carriers that can improve the pharmaceutical phase, pharmacokinetics and pharmacodynamics of well-known drugs. D-galactose is a simple, naturally occurring monosaccharide sugar that has been extensively studied for use as a carrier and has proven to be valuable in this role. With the aim of validating the galactose-prodrug approach, we have investigated the galactosylated prodrugs ibuprofen, ketoprofen, flurbiprofen and indomethacin, which we have named IbuGAL, OkyGAL, FluGAL and IndoGAL, respectively. Their physicochemical profiles in terms of lipophilicity, solubility and chemical stability have been evaluated at different physiological pH values, as have human serum stability and serum protein binding. Ex vivo intestinal permeation experiments were performed to provide preliminary insights into the oral bioavailability of the galactosylated prodrugs. Finally, their anti-inflammatory, analgesic and ulcerogenic activities were investigated in vivo in mice after oral treatment. The present results, taken together with those of previous studies, undoubtedly validate the galactosylated prodrug strategy as a problem-solving technique that can overcome the disadvantages of NSAIDs.
Collapse
Affiliation(s)
- Federica Sodano
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
- Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy; (B.R.); (E.M.); (L.L.)
- Correspondence: ; Tel.: +39-081-678-604
| | - Claudia Cristiano
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
| | - Barbara Rolando
- Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy; (B.R.); (E.M.); (L.L.)
| | - Elisabetta Marini
- Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy; (B.R.); (E.M.); (L.L.)
| | - Loretta Lazzarato
- Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy; (B.R.); (E.M.); (L.L.)
| | - Mariarosaria Cuozzo
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
| | - Stefania Albrizio
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
| | - Roberto Russo
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
| | - Maria Grazia Rimoli
- Department of Pharmacy, “Federico II” University of Naples, 80131 Naples, Italy; (C.C.); (M.C.); (S.A.); (R.R.); (M.G.R.)
| |
Collapse
|
7
|
Elias R, Basu P, Fridman M. Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles. J Med Chem 2022; 65:2361-2373. [PMID: 35084852 PMCID: PMC8842223 DOI: 10.1021/acs.jmedchem.1c01807] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
![]()
When used in combination
with azole antifungal drugs, cyclooxygenase
(COX) inhibitors such as ibuprofen improve antifungal efficacy. We
report the conjugation of a chiral antifungal azole pharmacophore
to COX inhibitors and the evaluation of activity of 24 hybrids. Hybrids
derived from ibuprofen and flurbiprofen were considerably more potent
than fluconazole and comparable to voriconazole against a panel of Candida species. The potencies of hybrids composed
of an S-configured azole pharmacophore were higher
than those with an R-configured pharmacophore. Tolerance,
defined as the ability of a subpopulation of cells to grow in the
presence of the drug, to the hybrids was lower than to fluconazole
and voriconazole. The hybrids were active against a mutant lacking
CYP51, the target of azole drugs, indicating that these agents act
via a dual mode of action. This study established that azole-COX inhibitor
hybrids are a novel class of potent antifungals with clinical potential.
Collapse
Affiliation(s)
- Rebecca Elias
- School of Chemistry, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 6997801, Israel
| | - Pallabita Basu
- School of Chemistry, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 6997801, Israel
| | - Micha Fridman
- School of Chemistry, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 6997801, Israel
| |
Collapse
|
8
|
Wang X, Ye X, Zhang Y, Ji F. Flurbiprofen suppresses the inflammation, proliferation, invasion and migration of colorectal cancer cells via COX2. Oncol Lett 2020; 20:132. [PMID: 32934701 PMCID: PMC7471702 DOI: 10.3892/ol.2020.11993] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Accepted: 07/02/2020] [Indexed: 12/15/2022] Open
Abstract
Colorectal cancer is an aggressive disease with a poor prognosis and low survival rate at the advanced stage, therefore new innovative targets are urgently required. Flurbiprofen has been reported to exhibit therapeutic effects in other types of cancer, such as esophageal cancer, breast cancer and colorectal cancer. Therefore, the present study aimed to investigate the function of flurbiprofen in colorectal cancer. SW620 colorectal cancer cells were treated with different concentrations of flurbiprofen to determine the optimum concentration. Subsequently, COX2 expression affected by flurbiprofen was tested using western blotting, reverse transcription-quantitative PCR and immunofluorescence. Enzyme-linked immunosorbent assay was used to determine the levels of tumor necrosis factor-α, interleukin (IL)-6 and IL-1β. Cell Counting Kit-8, colony formation and flow cytometry assays were used to assess the proliferation and apoptosis of SW620 cells in various groups. Western blotting was performed to investigate the expression of proliferation-, apoptosis- and migration-related proteins after different treatments. Wound healing and Transwell assays were performed to measure the invasion and migration of colorectal cancer cells, respectively. The results demonstrated that flurbiprofen inhibited colorectal cancer cell proliferation. Furthermore, it was identified that flurbiprofen inhibited the expression of COX2. Notably, flurbiprofen suppressed the expression of inflammatory factors by inhibiting COX2. Moreover, flurbiprofen inhibited the proliferation, invasion and migration of colorectal cancer cells by inhibiting COX2. In conclusion, the present study revealed that flurbiprofen inhibited COX2 expression in colorectal cancer, and affected the proliferation, invasion, migration and apoptosis of colorectal cancer cells. These results expand the understanding of the function of COX2 in colorectal cancer and the effect of flurbiprofen on COX2 expression.
Collapse
Affiliation(s)
- Xiaobo Wang
- Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| | - Xuxing Ye
- Traditional Medicine Center, Jinhua Hospital, Zhejiang University, Jinhua, Zhejiang 321000, P.R. China
| | - Yili Zhang
- Physical Examination Center, Jinhua Hospital, Zhejiang University, Jinhua, Zhejiang 321000, P.R. China
| | - Feng Ji
- Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
| |
Collapse
|
9
|
Sehajpal S, Prasad DN, Singh RK. Novel ketoprofen–antioxidants mutual codrugs as safer nonsteroidal anti‐inflammatory drugs: Synthesis, kinetic and pharmacological evaluation. Arch Pharm (Weinheim) 2019; 352:e1800339. [DOI: 10.1002/ardp.201800339] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Revised: 04/02/2019] [Accepted: 04/03/2019] [Indexed: 01/31/2023]
Affiliation(s)
- Shikha Sehajpal
- Department of Pharmaceutical ChemistryGujranwala Guru Nanak Khalsa College of Pharmacy, Civil LinesLudhiana Punjab India
| | - Deo Nandan Prasad
- Department of Pharmaceutical ChemistryShivalik College of PharmacyRupnagar Punjab India
| | - Rajesh K. Singh
- Department of Pharmaceutical ChemistryShivalik College of PharmacyRupnagar Punjab India
| |
Collapse
|
10
|
Ashraf Z, Mahmood T, Hassan M, Afzal S, Rafique H, Afzal K, Latip J. Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation. Drug Des Devel Ther 2019; 13:1643-1657. [PMID: 31190743 PMCID: PMC6524612 DOI: 10.2147/dddt.s178595] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
BACKGROUND The amide derivatives of nonsteroidal anti-inflammatory drugs have been reported to possess antitumor activity. The present work describes the synthesis of dexibuprofen amide analogues (4a-j) as potential anticancer agents. METHODS The title amides (4a-j) were obtained by simple nucleophilic substitution reaction of dexibuprofen acid chloride with substituted amines in good yield and chemical structures were confirmed by FTIR, 1H NMR, 13C NMR and mass spectral data. RESULTS The brine shrimp lethality assay results showed that all of the synthesized compounds are non-toxic to shrimp larvae. The inhibitory effects on tumor growth were evaluated and it was observed that N-(2,5-dichlorophenyl)-2-(4-isobutylphenyl) propionamide (4e) and N-(2-chlorophenyl)-2-(4-isobutylphenyl) propionamide (4g) exhibited excellent antitumor activity compared to all other derivatives. The compound 4e bearing 2,5-dichloro substituted phenyl ring and 4g possesses 2-chloro substituted phenyl ring exhibited 100% inhibition of the tumor growth. The anticancer activity was evaluated against breast carcinoma cell line (MCF-7) and it was observed that derivative 4e exhibited excellent growth inhibition of cancer cells with IC50 value of 0.01±0.002 µm, which is better than the standard drugs. The docking studies against breast cancer type 1 susceptibility protein BRCA1 (PDBID 3K0H) exhibited good binding affinities, which are in good agreement with the wet lab results. The compounds 4e and 4g showed the binding energy values of -6.39 and -6.34 Kcal/mol, respectively. The molecular dynamic (MD) simulation was also carried out to evaluate the residual flexibility of the best docking complexes of compounds 4e and 4g. The MD simulation analysis assured that the 4e formed a more stable complex with the target protein than the 4g. The synthesized amide derivatives exhibited were devoid of gastrointestinal side effects and no cytotoxic effects against human normal epithelial breast cell line (MCF-12A) were found. CONCLUSION Based upon our wet lab and dry lab findings we propose that dexibuprofen analogue 4e may serve as a lead structure for the design of more potent anticancer drugs.
Collapse
Affiliation(s)
- Zaman Ashraf
- Department of Chemistry, Allama Iqbal Open University, Islamabad, Pakistan
| | - Tariq Mahmood
- Department of Chemistry, Allama Iqbal Open University, Islamabad, Pakistan
| | - Mubashir Hassan
- Department of Biology, College of Natural Sciences, Kongju National University, Gongju, Republic of Korea
| | - Samina Afzal
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakria University, Multan, Pakistan
| | - Hummera Rafique
- Department of Chemistry, University of Gujrat, Gujrat, Pakistan
| | - Khurram Afzal
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahauddin Zakria University, Multan, Pakistan
| | - Jalifah Latip
- Department of Pharmaceutical Chemistry, School of Chemical Sciences & Food Technology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor, Malaysia,
| |
Collapse
|
11
|
Jyoti, Dheer D, Singh D, Kumar G, Karnatak M, Chandra S, Prakash Verma V, Shankar R. Thymol Chemistry: A Medicinal Toolbox. ACTA ACUST UNITED AC 2019. [DOI: 10.2174/1573407214666180503120222] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Background: Thymol is a natural phenolic monoterpenoid widely used in pharmaceutical and
food preservative applications. Thymol isomeric with carvacrol, extracted primarily from Thymus species
(Trachyspermum ammi) and other plants sources such as Baccharisgrise bachii and Centipeda minima,
has ethnopharmacological characteristics.
<p></p>
Methods: This review was prepared by analyzing articles published on thymol moiety in last decade and
selected from Science Direct, Scopus, Pub Med, Web of Science and SciFinder. The selected articles are
classified and gives brief introduction about thymol and its isolation, illustrates its natural as well as
synthetic sources, and also therapeutic benefits of thymol worldwide
<p></p>
Results: Thymol has been covering different endeavors such as antimicrobial, antioxidant, antiinflammatory,
antibacterial, antifungal, antidiarrhoeal, anthelmintic, analgesic, digestive, abortifacient,
antihypertensive, spermicidal, depigmenting, antileishmanial, anticholinesterase, insecticidal and many
others. This phenolic compound is among the essential scaffolds for medicinal chemists to synthesize
more bio-active molecules by further derivatization of the thymol moiety.
<p></p>
Conclusion: Thymol is an interesting scaffold due to its different activities and derivatization of thymol
is proved to enhance its biological activities. However, more robust, randomised, controlled clinical
trials would be desirable with well-characterised thymol preparations to corroborate its beneficial effects
in diseased patients. Moreover, in view of the potential use of thymol and thymol-rich essential oils in
the treatment of human infections, comprehensive studies on chronic and acute toxicity and also teratogenicity
are to be recommended.
Collapse
Affiliation(s)
- Jyoti
- Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
| | - Divya Dheer
- Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
| | - Davinder Singh
- Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
| | - Gulshan Kumar
- Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
| | - Manvika Karnatak
- Department of Chemistry, Banasthali University, Banasthali, Rajasthan 304022, India
| | - Suresh Chandra
- Genetics Resources & Agrotechnology Division, CSIR-IIIM, Jammu 180001, India
| | - Ved Prakash Verma
- Department of Chemistry, Banasthali University, Banasthali, Rajasthan 304022, India
| | - Ravi Shankar
- Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India
| |
Collapse
|
12
|
Agarwal H, Shanmugam VK. Anti-inflammatory activity screening of Kalanchoe pinnata methanol extract and its validation using a computational simulation approach. INFORMATICS IN MEDICINE UNLOCKED 2019. [DOI: 10.1016/j.imu.2019.01.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
|
13
|
|
14
|
Microwave-Assisted Synthesis, In Vivo Anti-Inflammatory and In Vitro Anti-Oxidant Activities, and Molecular Docking Study of New Substituted Schiff Base Derivatives. Pharm Chem J 2018. [DOI: 10.1007/s11094-018-1835-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
15
|
Aqeel MT, Ur-Rahman N, Khan AU, Ashraf Z, Latif M, Rafique H, Rasheed U. Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches. DRUG DESIGN DEVELOPMENT AND THERAPY 2018; 12:2443-2453. [PMID: 30127594 PMCID: PMC6089105 DOI: 10.2147/dddt.s158554] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Background Hyperlipidemia is a worth-mentioning risk factor in quickly expanding cardiovascular diseases, including myocardial infarction and, furthermore, in stroke. Methods The present work describes the synthesis of phenolic derivatives 4a–e and 6a–c with the aim of developing antihyperlipidemic agents. The structures of the synthesized compounds were confirmed by spectroscopic data. The in silico docking studies were performed against human 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase enzyme (PDB ID: 1HWK), and it was observed that compounds 4a and 6a exhibited maximum binding affinity with target protein having binding energies −8.3 and −7.9 kcal, respectively. Results Compound 4a interacts with amino acids Val805 with distance 1.89 Å and Met656, Thr558, and Glu559 with bonding distances 2.96, 2.70, and 2.20 Å, respectively. The in vivo antihyperlipidemic activity results revealed that compound 4a indicated minimum weight increment, ie, 20% compared with 35% weight increment with standard drug atorvastatin during 6 weeks of treatment. Moreover, increment in high-density lipoprotein cholesterol and decrease in total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels were more prominent in case of 4a compared to atorvastatin with P<0.05. The synthesized compounds were nontoxic and well tolerated because none of the mice were found to suffer from any kind of morbidity and death during 6 weeks of dosing. Conclusion Based on our pharmacological evaluation, we may propose that compound 4a may act as a lead structure for the design and development of more potent antihyperlipidemic drugs.
Collapse
Affiliation(s)
- Muhammad Tahir Aqeel
- Department of Pharmacy, COMSATS Institute of Information Technology Abbottabad, Abbottabad, Pakistan
| | - Nisar Ur-Rahman
- Department of Pharmacy, COMSATS Institute of Information Technology Abbottabad, Abbottabad, Pakistan
| | - Arif-Ullah Khan
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan
| | - Zaman Ashraf
- Department of Chemistry, Allama Iqbal Open University, Islamabad, Pakistan,
| | - Muhammad Latif
- College of Medicine, Centre for Genetics and Inherited Diseases (CGID), Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
| | - Hummera Rafique
- Department of Chemistry, University of Gujrat, Gujrat, Pakistan
| | - Usman Rasheed
- Department of Pharmacy, COMSATS Institute of Information Technology Abbottabad, Abbottabad, Pakistan
| |
Collapse
|
16
|
Peesa JP, Atmakuri LR, Yalavarthi PR, Mandava Venkata BR, Rasheed A, Pachava V. Oxaprozin prodrug as safer nonsteroidal anti-inflammatory drug: Synthesis and pharmacological evaluation. Arch Pharm (Weinheim) 2017; 351. [PMID: 29283449 DOI: 10.1002/ardp.201700256] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2017] [Revised: 11/25/2017] [Accepted: 11/30/2017] [Indexed: 11/11/2022]
Abstract
Oxaprozin is a popular non-steroidal anti-inflammatory drug (NSAID) and its chronic oral use is clinically restricted due to its gastrointestinal (GI) complications. In order to circumvent the GI complications, oxaprozin was amended as a prodrug in a one-pot reaction using N,N-carbonyldiimidazole as an activating agent. Dextran of average molecular weight (60,000-90,000 Da) was exploited as a carrier in the process of oxaprozin prodrug production by esterification. The structural profiles of the synthesized oxaprozin prodrug were characterized by FT-IR and NMR spectroscopy. The oxaprozin prodrug possessed optimal molecular weight, lipophilicity, partition coefficient, protein binding, and degree of substitution of 52.4%. The release of oxaprozin upon hydrolysis of the prodrug in both simulated gastric fluid and simulated intestinal fluid followed first-order kinetics with 55.2 min of half-life. Varied ADME properties of the prodrug resulted upon Schrodinger's QikProp tool application. Oxaprozin prodrug displayed significant analgesic, antipyretic, and anti-inflammatory activities, with a remarkable decrease in the ulcer index and being devoid of antigenicity in experimental animals. Thus, it is evident that oxaprozin prodrug is a safer oral NSAID without causing any ulcerations.
Collapse
Affiliation(s)
- Jaya P Peesa
- Department of Pharmaceutical Chemistry, Sree Vidyanikethan College of Pharmacy, Tirupati, India.,Centre for Research Studies, Krishna University, Machillipatnam, India
| | - Lakshmana R Atmakuri
- Department of Pharmaceutical Chemistry, V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, India
| | | | | | - Arun Rasheed
- Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy, Poonthavanam, Malappuram, India
| | - Vengalrao Pachava
- Department of Pharmacology, JSS College of Pharmacy, Rocklands, Ooty, India
| |
Collapse
|